Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ADOPTED
by methodical conference
of faculty pediatrics department
________________________
Head of the chair professor Nedel'ska S.M.
"___" ___________ 2017__
Zaporizhzhуa 2017
Actuality of the topic:
Because the potential for SCD in most children with dysrhythmias is low,
treatment is frequently instituted to avoid bothersome symptoms. In older children,
dysrhythmia symptoms are reported in familiar terms, such as palpitations,
dizziness, racing heart, and so forth. In younger children, particularly infants,
symptoms may be harder to elicit or may be expressed in more obtuse terms (e.g.,
“chest pains”). Because a younger child may not always be reliable in reporting
symptoms, prophylactic treatment of certain rhythm disturbances is sometimes
instituted to avoid the consequences of a prolonged, unrecognized, sustained
arrhythmia that could result in significant morbidity. Conversely, in an older child,
symptoms of dysrhythmias are more reliably reported, so treatment on an as-
needed basis may be an effective alternative.
Two different treatment modalities may be used for dysrhythmias. The traditional
treatment option involves antiarrhythmic medications. Drugs can be taken every
day to avoid dysrhythmia symptoms or can be taken as needed when symptoms
occur. Very few antiarrhythmic agents are officially formulated for pediatric use.
Only a small number of well-controlled studies outline the effective use of specific
antiarrhythmic agents in children. In certain cases, antiarrhythmic agents
manufactured only in tablets or capsules have to be modified by pharmacies to a
suspension form for use in children. Powerful antiarrhythmic agents such as
amiodarone, flecainide, sotalol, and procainamide are examples of such drugs.
Thus advanced pharmacologic treatment of childhood dysrhythmias can be quite
challenging.
1. Goals:
Morganie-Adam-Stocks syndrom.
2. To indicate etiologic and pathophysiologic factors at cardiac arrhythmia in children.
3. To classify, analyze typical clinics of the cardiac arrhythmia.
4. To make list of the examination and to analyze data of the laboratory and
instrumental examination at cardiac arrhythmia.
5. To prescribe treatment, rehabilitation, prophylaxis of the paroxysmal tachycardia,
atrial flutter, atrial fibrillation, atrioventricular block, Morgainie-Adam-Stocks
syndrom.
6. To diagnose and to give the first medical aim at cardiac arrhythmia: paroxysmal
tachycardia, atrial flutter, atrial fibrillation, atrioventricular block, Morganie-Adam-
Stocks syndrom.
7. To perform differential diagnostic of cardiac arrhythmia in children
8. To make prognosis at cardiac arrhythmia.
9. To demonstrate knowledge of moral and deontological principles and
principles of professional subordination in child's cardioreumatology.
3. Base level of training, skills and knowledge.
Discipline Skills which must be got by students
Anatomy, To know the anatomo-physiological features of
Physiology organs of the heart.
Path. аnatomy, To define the indexes of organs of the
cardiovascular system, functions of organs of the
Path. рhysiology cardiovascular system. To know the etiology and
pathogenesis aspects acute heart failure in
children.
Introduction to the child's To own a research method and semiotics of diseases
diseases of organs of the cardiovascular system, leadthrough of
laboratory methods of research (clinical blood,
clinical and biochemical blood tests; coagulogram;
immunological data of 1 level; electrocardiogram,
X-ray, ultrasound heart research); instrumental and
functional methods of research.
X-ray To own the X-ray methods of diagnostics of organs
of the heart. To appoint and estimate the results of
X-ray methods of inspection.
Pharmacology To write preparations: glicosides, antyarrhythmici,
adrenoblockers, preparations of potassium,
magnesium.
To study indications, to prescribe and write recipes
with the proper remedies.
Cardiac Dysrhythmias
Key Concepts
▪ The cornerstone of effective therapy for a specific pediatric dysrhythmia first
involves obtaining an accurate diagnosis.
▪ More harm can be done by assuming a pathologic dysrhythmia exists solely
on the basis of the clinical history and thus adopting a specific therapy that is
either ineffective or unnecessary.
▪ It is most important to attempt to record and diagnose the dysrhythmia (via
surface electrocardiography, Holter monitor, event recorder, electrophysiology
study, or a combination of these modalities) before initiating therapy.
▪ Documenting the diagnosis before treatment is the foundation of accurate
therapy for pediatric dysrhythmia.
Finally, certain rarer SVTs from arrhythmia mechanisms confined to the atria
(atrial flutter, atrial ectopic tachycardias [AETs]) can occur in children. Atrial
flutter usually occurs at birth or during early infancy. Once the arrhythmia is
terminated (cardioversion or spontaneously), the need for chronic treatment
(digoxin or propranolol) beyond 1 year of age is rare. AET is an incessant
tachycardia in children that is difficult to treat with antiarrhythmic agents. It is
frequently manifested as a cardiomyopathy because of its incessant nature.
Treatment of AET may involve the use of β-blockers, class I or III antiarrhythmic
agents, or catheter ablation. Success rates for catheter ablation of AET are lower
than with re-entrant SVTs because of a high recurrence rate and the possibility of
multiple foci causing the AET.
Ventricular Tachycardia
VT is a rare but important dysrhythmia in the pediatric population because of the
implication involving SCD. In reality, most VTs encountered in children are
associated with normal cardiac structure and function; treatment strategies in this
scenario usually involve mitigating bothersome symptoms rather than attempting
to decrease the incidence of SCD. In contrast, when ventricular arrhythmias are
encountered in children with heart disease (postoperative congenital heart disease,
cardiomyopathies), treatment is primarily directed at preventing SCD. In most
pediatric cardiac disease entities associated with VTs, no pharmacologic or
nonpharmacologic therapies are rigorously proved to decrease the incidence of
SCD. Also, with the issues of proarrhythmia magnified in children with structural
heart disease, more consideration is being given to defibrillator implantation rather
than antiarrhythmic therapy to mitigate the risk of SCD caused by ventricular
arrhythmias in this patient population. These trends, however, are based on
extrapolation of data involving adult SCD caused by VT secondary to coronary
artery disease.
Chronic treatment of VTs in children with abnormal cardiac structure and function
usually involves the use of therapies that can prevent SCD. In the past, ventricular
arrhythmias encountered in such disease states as dilated cardiomyopathy,
hypertrophic cardiomyopathy, and postoperative congenital heart disease were
treated with antiarrhythmic medications such as procainamide, flecainide, sotalol,
and amiodarone. However, concern about the lack of efficacy and the
proarrhythmic potential of these medications made chronic pharmacologic therapy
a less attractive alternative for these conditions. The use of device therapy
(defibrillation implantation) to prevent SCD in the pediatric population has
increased. However, these devices are not always pediatric friendly, and their use
in the pediatric population has a unique set of problems.
Two pediatric disease states in which ventricular arrhythmias are common deserve
special mention. The first is the long QT syndrome, a genetic condition in which
disorders of either sodium or potassium myocardial ionic channels cause
repolarization abnormalities and the propensity for malignant ventricular
arrhythmias (torsades de pointes). SCD is a frequent outcome in this condition.
The initial treatment of long QT syndrome involves the use of a β-blocker
(propranolol) and activity restriction. Second-line therapy includes the use of
mexiletine (class I antiarrhythmic agent), cardiac sympathectomy, or defibrillator
implantation.
VT occurring in infancy is another unique arrhythmia. Similar to SVT, when VT is
encountered in infancy, it may be characterized by symptoms of cardiogenic shock
as a result of its incessant, unrecognized nature. The substrate underlying
ventricular arrhythmias in infancy is usually hamartomatous lesions (plaques) on
the ventricular myocardium that exhibit abnormal automaticity and cause
ventricular irritability. These hamartomas usually resolve by 5 years of age, and the
VT subsides. Until they resolve, these VTs in infancy may require very powerful
class I or III antiarrhythmic agents alone or in combination to avoid severe
symptoms. On occasion, for medically recalcitrant infantile VT, ablation (either
surgical or catheter) therapy is needed to avoid severe mobility or mortality.
However, despite the severe initial symptoms, most children with this condition
become free of tachycardia without the necessity of any therapy by 4 to 5 years of
age.
Premature Beats
Premature beats (especially from the ventricle), when encountered in children with
abnormal cardiac structure, function, or both, may be of concern because of issues
involving prevention of SCD. Although these beats may not require any specific
treatment, re-examination of the underlying cardiac substrate may be necessary. A
new onset of cardiac ectopy sometimes indicates a cardiac substrate that is
changing for the worse. In addition, some restriction of activity in children with
cardiac structural disease and new-onset ectopy may at times be warranted.
Bradycardia
Bradyarrhythmias encountered in children that are significant enough to need
treatment are extremely rare. If significant sinus bradycardia is encountered in a
child with a normal heart, most likely the cause of this arrhythmia is not cardiac. A
workup of noncardiac reasons for bradycardia is imperative and includes ruling out
apnea, intracranial pathology, endocrine abnormalities, and other systemic
diseases. Because the only reliable cardiac treatment of chronic, hemodynamically
significant sinus bradycardia is permanent cardiac pacing, searching for other
causes of the bradycardia is crucial.
Meaning:
Classified under:
Synonyms:
2.A child of 7yrs suffering from the age of 4 yrs from pneumonia,a complication of
pulmonary heart is developed, what are the characteristic indication of this on
the ECG?
A. high P wave
B. Leftgram
C. Lower P wave
D. ST on the isolinea
E. Low T wave
3.A child was admitted in the hospital with infectious –allergic myocaditis, in
the 2nd day there he faced attack of paroxysmal tachycardia, which of the
following drugs is used to avoid attacl?
A. Nor epinephrine
B. Cardiac glycosides
C. Morphine
D. Finoptin(Isoptin)
E. Hinidine
4.A 8 mo old baby is suffering from adenoviral infection, with high t. the PS is
220\min, after 6 hrs the condition got worsened, child became pale, irritable,
increased tachypnoea. Abdomen is soft, liver +2.5cm from the costal edges, On
ECG-paroxysmal supra ventricular tachychadia. Which of the the tactics is the
most suitable?
A. TO complete Valsalva manuever
B. cooling the Face with ice block
C. Drink cold water
D. IV injection of Lidocaine
E. Per oral Anaprilin
5. There is a 14 yrs old girl with diagnosis of vegetative disfunction with tonus
of sympathetic part of the vegetative NS, what is the most suitable diet?
A. Addition of protein and fat
B. Control of protein and carbohydrates
C. Control of protein and fat
D. Addition of fat and carbohydrates
7. Boy of 3yrs.Is discharged from cardiology, where he was admitted due to often
attack of cyanotic dispnoea with a Teetrad Fallow, which of the following drug
is most suitable to take as prophylaxis?
A. Curantil
B. Relanium
C. Digoxin
D. Obzidan
E. Cordaron
Tests 2.
1. A 5yrs. Old child suddenly had an attack of palpitation, accompanied with
nausea, headache and weakness, On ECG – tachycardia of 220\min. ventricular
complex fixed and widened, P waves is absent, what drug will you give first?
A. Lidocaine
B. Izoptin
C. Seduxin
D. Novocainamide
E. Strophanthin
3. a boy of 7yrs. Is having congenital defect of the heart , for the last time
there is an increased paleness of the skin, peri-oral acrocyanosis in the time of
rest, BR:36\min, HR=PS=102\min, oedema on the legs, liver +6cm, what type
cardiac insufficiency is observed?
A. Total cardiac insufficiency
B. Chr. Left ventricular incompetence IIB
C. Chronic right ventricular in sufficiency
D. Chronic right ventricular incompetence IIA
E. Chr. Right ventricular insufficiency IIA
Questions
1To indicate etiologic and pathophysiologic factors at premature contraction at
paroxysmal tachycardia, atrial flutter, atrial fibrillation, atrioventricular block, Moraine-
Adam-Stocks syndrom.
2To indicate etiologic and pathophysiologic factors at cardiac arrhythmia in children.
1. Determination paroxysmal tachycardia, atrial flutter, atrial fibrillation,
atrioventricular block, Moraine-Adam-Stocks syndrom.
2. Classification cardiac arrhythmia in children.